Search results - 13 results
A comparison of COVID-19 incidence rates across six European countries in 2021.
David; Pistol, Adriana; Javiera Rebolledo; Riccardo, Flavia; Riess, Maximilian; Rusu, Lavinia Cipriana; Che, Didier; Coignard, Bruno; COVID-19 Study group; COVID-19 Study Group members Source: Euro ...
Epidemiology of COVID-19 mortality in Belgium from wave 1 to wave 7 (March 2020 – 11 September 2022)
week 15 2020). Age and sex 91.8% of the COVID-19 deaths were 65 years and older. The median age of COVID-19 deaths was 84 years old and the average age was 81.6 years old. In all age groups up to 80-84 ...
Epidémiologie de la mortalité COVID-19 en Belgique de la vague 1 à la vague 7 (mars 2020- 11 septembre 2022)
et plus. L’âge médian des décès dus à la COVID-19 était de 84 ans et l’âge moyen de 81,6 ans. Dans tous les groupes d’âge jusqu’à 80-84 ans, les hommes ont représenté la fraction la plus élevée des décès dus ...
Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults.
Antibodies, Viral BNT162 Vaccine Breakthrough Infections COVID-19 COVID-19 Vaccines Humans Immunity nursing homes Population Groups RNA, Messenger SARS-CoV-2 Abstract: BACKGROUND: Nursing home residents, ...
SARS-CoV-2 Surveillance in Belgian Wastewaters
fourth virus wave and were considered complementary and valuable information to conventional epidemiological indicators in the weekly wastewater reports communicated to the National Risk Assessment Group ...
The Relation between Perceived and Actual Understanding and Adherence: Results from a National Survey on COVID-19 Measures in Belgium.
understanding included being male and belonging to a younger age group, while risk factors for actual understanding were speaking French (versus Dutch) and belonging to a lower socio-economic level. Communication ...
Early high antibody-titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma.
the prospective multicentre DAWN-plasma trial, adult patients hospitalised with COVID-19 were randomised to 4 units of open-label convalescent plasma combined with standard of care (intervention group ...
Monitoring of human coronaviruses in Belgian primary care and hospitals, 2015-20: a surveillance study.
admitted to hospital with seasonal hCoV infections by age group. Samples received from week 8, 2020, were tested for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Findings: 2573 primary care ...
Consultations Corona: Participation citoyenne à la politique Belge de vaccination
COVID-19 participation citoyenne Vaccination Abstract: Le but des consultations corona était de faire en sorte que différents groupes de citoyens belges puissent délibérer d’une manière informée sur les ...
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the DAWn-Plasma trial.
absence of an alternative diagnosis. Patients are randomized in a 2:1 ratio to either standard of care and convalescent plasma (active treatment group) or standard of care only. The active treatment group ...